

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.90556957 |
| 2 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.90556957 |
| 3 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.62928560 |
| 4 | negative T cell selection (GO:0043383) | 5.36594454 |
| 5 | negative thymic T cell selection (GO:0045060) | 5.11286292 |
| 6 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.90961232 |
| 7 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.86648977 |
| 8 | ribosomal small subunit assembly (GO:0000028) | 4.81716028 |
| 9 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.61929799 |
| 10 | leukocyte aggregation (GO:0070486) | 4.38842228 |
| 11 | negative regulation of cell killing (GO:0031342) | 4.36785458 |
| 12 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.36785458 |
| 13 | positive thymic T cell selection (GO:0045059) | 4.34436025 |
| 14 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 4.20984610 |
| 15 | interferon-gamma production (GO:0032609) | 4.19147243 |
| 16 | thymic T cell selection (GO:0045061) | 4.17281816 |
| 17 | positive T cell selection (GO:0043368) | 4.15302265 |
| 18 | regulation of gamma-delta T cell activation (GO:0046643) | 4.15107715 |
| 19 | response to interleukin-15 (GO:0070672) | 4.09957253 |
| 20 | T cell selection (GO:0045058) | 4.03387185 |
| 21 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 4.02195188 |
| 22 | regulation of isotype switching to IgG isotypes (GO:0048302) | 3.92347079 |
| 23 | T cell migration (GO:0072678) | 3.90232190 |
| 24 | viral transcription (GO:0019083) | 3.85939198 |
| 25 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.83567500 |
| 26 | regulation of tolerance induction (GO:0002643) | 3.80971140 |
| 27 | DNA deamination (GO:0045006) | 3.76946468 |
| 28 | telomere maintenance via semi-conservative replication (GO:0032201) | 3.73574946 |
| 29 | translational termination (GO:0006415) | 3.71425859 |
| 30 | cellular response to interleukin-15 (GO:0071350) | 3.71067497 |
| 31 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.69220955 |
| 32 | DNA strand elongation involved in DNA replication (GO:0006271) | 3.66689360 |
| 33 | alpha-beta T cell differentiation (GO:0046632) | 3.61527048 |
| 34 | T cell receptor signaling pathway (GO:0050852) | 3.58857057 |
| 35 | DNA strand elongation (GO:0022616) | 3.51820003 |
| 36 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.49826788 |
| 37 | mast cell activation (GO:0045576) | 3.49581349 |
| 38 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 3.45954440 |
| 39 | positive regulation of T cell differentiation in thymus (GO:0033089) | 3.45004617 |
| 40 | DNA unwinding involved in DNA replication (GO:0006268) | 3.41079405 |
| 41 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 3.37095991 |
| 42 | translational elongation (GO:0006414) | 3.33773717 |
| 43 | alpha-beta T cell activation (GO:0046631) | 3.30359005 |
| 44 | lymphocyte migration (GO:0072676) | 3.29817454 |
| 45 | regulation of T cell tolerance induction (GO:0002664) | 3.28907634 |
| 46 | T cell costimulation (GO:0031295) | 3.28559700 |
| 47 | T cell homeostasis (GO:0043029) | 3.28024078 |
| 48 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.27488539 |
| 49 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 3.27120423 |
| 50 | cellular response to type I interferon (GO:0071357) | 3.27028071 |
| 51 | type I interferon signaling pathway (GO:0060337) | 3.27028071 |
| 52 | mucosal-associated lymphoid tissue development (GO:0048537) | 3.26953313 |
| 53 | Peyers patch development (GO:0048541) | 3.26953313 |
| 54 | response to type I interferon (GO:0034340) | 3.25662812 |
| 55 | positive regulation of humoral immune response (GO:0002922) | 3.24633076 |
| 56 | maturation of SSU-rRNA (GO:0030490) | 3.23689784 |
| 57 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 3.23637455 |
| 58 | ribosomal small subunit biogenesis (GO:0042274) | 3.23524545 |
| 59 | lymphocyte costimulation (GO:0031294) | 3.23005578 |
| 60 | telomere maintenance via recombination (GO:0000722) | 3.21710196 |
| 61 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.21064167 |
| 62 | DNA replication initiation (GO:0006270) | 3.20228098 |
| 63 | regulation of cell killing (GO:0031341) | 3.19754307 |
| 64 | antigen receptor-mediated signaling pathway (GO:0050851) | 3.18927668 |
| 65 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 3.18552214 |
| 66 | negative regulation of T cell apoptotic process (GO:0070233) | 3.18216811 |
| 67 | tolerance induction (GO:0002507) | 3.17121878 |
| 68 | cotranslational protein targeting to membrane (GO:0006613) | 3.15449177 |
| 69 | regulation of alpha-beta T cell activation (GO:0046634) | 3.14243532 |
| 70 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.13481838 |
| 71 | protein targeting to ER (GO:0045047) | 3.13406334 |
| 72 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.11862039 |
| 73 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 3.11266713 |
| 74 | CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294) | 3.10887123 |
| 75 | T-helper cell differentiation (GO:0042093) | 3.10887123 |
| 76 | detection of bacterium (GO:0016045) | 3.09602059 |
| 77 | regulation of granulocyte differentiation (GO:0030852) | 3.07967881 |
| 78 | positive regulation of cell killing (GO:0031343) | 3.07540910 |
| 79 | negative regulation of interleukin-12 production (GO:0032695) | 3.06111893 |
| 80 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 3.06027295 |
| 81 | positive regulation of isotype switching (GO:0045830) | 3.05609792 |
| 82 | positive regulation of B cell differentiation (GO:0045579) | 3.04701736 |
| 83 | mitotic recombination (GO:0006312) | 3.03961170 |
| 84 | dendritic cell chemotaxis (GO:0002407) | 3.03758957 |
| 85 | detection of other organism (GO:0098543) | 3.03756192 |
| 86 | positive regulation of interleukin-4 production (GO:0032753) | 3.03708937 |
| 87 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.03057405 |
| 88 | negative regulation of phagocytosis (GO:0050765) | 3.02548460 |
| 89 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 2.97844998 |
| 90 | positive regulation by symbiont of host defense response (GO:0052509) | 2.97371994 |
| 91 | modulation by symbiont of host defense response (GO:0052031) | 2.97371994 |
| 92 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.97371994 |
| 93 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.97371994 |
| 94 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.97371994 |
| 95 | modulation by symbiont of host immune response (GO:0052553) | 2.97371994 |
| 96 | CD4-positive, alpha-beta T cell differentiation (GO:0043367) | 2.96770511 |
| 97 | response to muramyl dipeptide (GO:0032495) | 2.96739259 |
| 98 | protein localization to endoplasmic reticulum (GO:0070972) | 2.95552122 |
| 99 | regulation of B cell differentiation (GO:0045577) | 2.95115625 |
| 100 | V(D)J recombination (GO:0033151) | 2.95027177 |
| 101 | negative regulation of innate immune response (GO:0045824) | 2.93141907 |
| 102 | cellular extravasation (GO:0045123) | 2.92920938 |
| 103 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.92652807 |
| 104 | positive regulation of tolerance induction (GO:0002645) | 2.92158976 |
| 105 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.91918123 |
| 106 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.88850453 |
| 107 | positive regulation of interleukin-2 production (GO:0032743) | 2.87886730 |
| 108 | positive regulation of granulocyte differentiation (GO:0030854) | 2.87598078 |
| 109 | cellular protein complex disassembly (GO:0043624) | 2.87248185 |
| 110 | cellular response to interleukin-4 (GO:0071353) | 2.86428588 |
| 111 | viral life cycle (GO:0019058) | 2.86413090 |
| 112 | * regulation of T cell receptor signaling pathway (GO:0050856) | 2.84791598 |
| 113 | translational initiation (GO:0006413) | 2.84658925 |
| 114 | regulation of isotype switching (GO:0045191) | 2.84558437 |
| 115 | * regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.81663872 |
| 116 | T cell differentiation (GO:0030217) | 2.79675673 |
| 117 | regulation of response to interferon-gamma (GO:0060330) | 2.75622208 |
| 118 | telomere maintenance via telomere lengthening (GO:0010833) | 2.75064056 |
| 119 | mast cell degranulation (GO:0043303) | 2.73550173 |
| 120 | mast cell activation involved in immune response (GO:0002279) | 2.73550173 |
| 121 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 2.72398250 |
| 122 | DNA replication checkpoint (GO:0000076) | 2.71528838 |
| 123 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.70150753 |
| 124 | nucleotide-excision repair, DNA gap filling (GO:0006297) | 2.68234854 |
| 125 | NIK/NF-kappaB signaling (GO:0038061) | 2.65910140 |
| 126 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.65861262 |
| 127 | lymphocyte homeostasis (GO:0002260) | 2.65328332 |
| 128 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.63433646 |
| 129 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.63433646 |
| 130 | negative regulation of T cell mediated immunity (GO:0002710) | 2.63264836 |
| 131 | regulation of regulatory T cell differentiation (GO:0045589) | 2.61174473 |
| 132 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 2.60770357 |
| 133 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 2.60770357 |
| 134 | protein localization to kinetochore (GO:0034501) | 2.59337039 |
| 135 | protein complex disassembly (GO:0043241) | 2.58978824 |
| 136 | activated T cell proliferation (GO:0050798) | 2.58485345 |
| 137 | regulation of protein heterodimerization activity (GO:0043497) | 2.58382924 |
| 138 | T cell activation (GO:0042110) | 2.56554528 |
| 139 | B cell receptor signaling pathway (GO:0050853) | 2.55331437 |
| 140 | positive regulation of DNA recombination (GO:0045911) | 2.54635046 |
| 141 | regulation of B cell mediated immunity (GO:0002712) | 2.54595809 |
| 142 | response to interleukin-4 (GO:0070670) | 2.54327258 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 7.73243679 |
| 2 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.70690877 |
| 3 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.38823422 |
| 4 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.26557460 |
| 5 | MYC_22102868_ChIP-Seq_BL_Human | 2.92826806 |
| 6 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.76819082 |
| 7 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.69002143 |
| 8 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.67240858 |
| 9 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.65423637 |
| 10 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.65161616 |
| 11 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.59946762 |
| 12 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.58224144 |
| 13 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.53148236 |
| 14 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.47047260 |
| 15 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.35068204 |
| 16 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.33695777 |
| 17 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.28702828 |
| 18 | MYB_26560356_Chip-Seq_TH2_Human | 2.27917076 |
| 19 | * TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.10057179 |
| 20 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.08892567 |
| 21 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.05216723 |
| 22 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.04766716 |
| 23 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.02981999 |
| 24 | * SCL_19346495_ChIP-Seq_HPC-7_Human | 2.02172023 |
| 25 | * MAF_26560356_Chip-Seq_TH1_Human | 2.00253018 |
| 26 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.98137205 |
| 27 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.96997241 |
| 28 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.95927151 |
| 29 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.95167327 |
| 30 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.94876079 |
| 31 | UTX_26944678_Chip-Seq_JUKART_Human | 1.93795192 |
| 32 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.93476190 |
| 33 | GATA3_26560356_Chip-Seq_TH2_Human | 1.93343769 |
| 34 | MYB_26560356_Chip-Seq_TH1_Human | 1.93214498 |
| 35 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.90996056 |
| 36 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.85738592 |
| 37 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.85689803 |
| 38 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.85597948 |
| 39 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.85045766 |
| 40 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.81731719 |
| 41 | SPI1_23127762_ChIP-Seq_K562_Human | 1.80982562 |
| 42 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.80606305 |
| 43 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.80102552 |
| 44 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.79571966 |
| 45 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.78482777 |
| 46 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.73727913 |
| 47 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.73624507 |
| 48 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.72849446 |
| 49 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.72760371 |
| 50 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.70183446 |
| 51 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.68531167 |
| 52 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.65817641 |
| 53 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.64517123 |
| 54 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.63673653 |
| 55 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.62837250 |
| 56 | * ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.58887732 |
| 57 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.58715488 |
| 58 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.57363293 |
| 59 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.56771743 |
| 60 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.56734034 |
| 61 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.53371741 |
| 62 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.52082351 |
| 63 | MAF_26560356_Chip-Seq_TH2_Human | 1.49748028 |
| 64 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.48306836 |
| 65 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.43256201 |
| 66 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.42946285 |
| 67 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.40525469 |
| 68 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.39683028 |
| 69 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.35947141 |
| 70 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.34564511 |
| 71 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.33168697 |
| 72 | GATA1_22025678_ChIP-Seq_K562_Human | 1.33003723 |
| 73 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.31988790 |
| 74 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.31509119 |
| 75 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.31103056 |
| 76 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.30826523 |
| 77 | * MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.29889933 |
| 78 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.28941280 |
| 79 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.28556161 |
| 80 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.26738605 |
| 81 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.23644310 |
| 82 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 1.23020861 |
| 83 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.22688799 |
| 84 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.22255734 |
| 85 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.22091036 |
| 86 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.21079262 |
| 87 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.17476047 |
| 88 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.16852532 |
| 89 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.15181658 |
| 90 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.13236263 |
| 91 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.12397441 |
| 92 | GATA1_19941826_ChIP-Seq_K562_Human | 1.10583491 |
| 93 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.10483556 |
| 94 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.10273194 |
| 95 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.09943861 |
| 96 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.09898488 |
| 97 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.09102937 |
| 98 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.08794107 |
| 99 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.08267167 |
| 100 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.08161843 |
| 101 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.07435137 |
| 102 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.07387563 |
| 103 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.07034478 |
| 104 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.06638131 |
| 105 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.06395772 |
| 106 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.05445224 |
| 107 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.04515101 |
| 108 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.03865175 |
| 109 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.03071864 |
| 110 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.02928830 |
| 111 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.01890508 |
| 112 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.01302345 |
| 113 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.01001423 |
| 114 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.00358103 |
| 115 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.00246437 |
| 116 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 0.99896052 |
| 117 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 0.98256086 |
| 118 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 0.98229115 |
| 119 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 0.97856825 |
| 120 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 0.97465809 |
| 121 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.96077792 |
| 122 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.95532395 |
| 123 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.94886509 |
| 124 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.94608266 |
| 125 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 0.94396233 |
| 126 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.94019376 |
| 127 | * FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.93682318 |
| 128 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.93458380 |
| 129 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.93354861 |
| 130 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.93172230 |
| 131 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.93066917 |
| 132 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.92280050 |
| 133 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.88958805 |
| 134 | * RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.87832174 |
| 135 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.87354164 |
| 136 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.85966656 |
| 137 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.84803168 |
| 138 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.82408982 |
| 139 | GATA3_26560356_Chip-Seq_TH1_Human | 0.81165379 |
| 140 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.79232718 |
| 141 | * GATA2_19941826_ChIP-Seq_K562_Human | 0.77078651 |
| 142 | P300_27268052_Chip-Seq_Bcells_Human | 0.76723033 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003763_abnormal_thymus_physiology | 4.79418617 |
| 2 | MP0005671_abnormal_response_to | 3.79580335 |
| 3 | MP0002396_abnormal_hematopoietic_system | 3.70307836 |
| 4 | MP0001835_abnormal_antigen_presentation | 3.06863669 |
| 5 | MP0000685_abnormal_immune_system | 2.95996112 |
| 6 | MP0009333_abnormal_splenocyte_physiolog | 2.87863762 |
| 7 | MP0002166_altered_tumor_susceptibility | 2.83478034 |
| 8 | MP0002398_abnormal_bone_marrow | 2.77642644 |
| 9 | MP0003693_abnormal_embryo_hatching | 2.64049676 |
| 10 | MP0001800_abnormal_humoral_immune | 2.63743908 |
| 11 | MP0009785_altered_susceptibility_to | 2.54979475 |
| 12 | MP0002420_abnormal_adaptive_immunity | 2.52453310 |
| 13 | MP0008057_abnormal_DNA_replication | 2.52042271 |
| 14 | MP0010094_abnormal_chromosome_stability | 2.49446525 |
| 15 | MP0000703_abnormal_thymus_morphology | 2.48298280 |
| 16 | MP0001819_abnormal_immune_cell | 2.48125810 |
| 17 | MP0005000_abnormal_immune_tolerance | 2.40477827 |
| 18 | MP0002723_abnormal_immune_serum | 2.34819915 |
| 19 | MP0002722_abnormal_immune_system | 2.33877743 |
| 20 | MP0005025_abnormal_response_to | 2.31162191 |
| 21 | MP0000716_abnormal_immune_system | 2.30948640 |
| 22 | MP0002006_tumorigenesis | 2.29712619 |
| 23 | MP0000689_abnormal_spleen_morphology | 2.25962777 |
| 24 | MP0002452_abnormal_antigen_presenting | 2.21204491 |
| 25 | MP0002405_respiratory_system_inflammati | 2.20504144 |
| 26 | MP0003436_decreased_susceptibility_to | 2.20223524 |
| 27 | MP0003724_increased_susceptibility_to | 2.14047435 |
| 28 | MP0001790_abnormal_immune_system | 2.11575704 |
| 29 | MP0005387_immune_system_phenotype | 2.11575704 |
| 30 | MP0002429_abnormal_blood_cell | 2.04823514 |
| 31 | MP0001873_stomach_inflammation | 2.04411246 |
| 32 | MP0003077_abnormal_cell_cycle | 2.03511998 |
| 33 | MP0001545_abnormal_hematopoietic_system | 2.02138307 |
| 34 | MP0005397_hematopoietic_system_phenotyp | 2.02138307 |
| 35 | MP0003111_abnormal_nucleus_morphology | 2.01141509 |
| 36 | MP0005075_abnormal_melanosome_morpholog | 1.96205189 |
| 37 | MP0005464_abnormal_platelet_physiology | 1.95555533 |
| 38 | MP0004808_abnormal_hematopoietic_stem | 1.93810661 |
| 39 | MP0010155_abnormal_intestine_physiology | 1.92431228 |
| 40 | MP0000490_abnormal_crypts_of | 1.91598508 |
| 41 | MP0004957_abnormal_blastocyst_morpholog | 1.90637126 |
| 42 | MP0003866_abnormal_defecation | 1.86557163 |
| 43 | MP0002419_abnormal_innate_immunity | 1.84188986 |
| 44 | MP0002148_abnormal_hypersensitivity_rea | 1.78239261 |
| 45 | MP0001853_heart_inflammation | 1.62065253 |
| 46 | MP0000465_gastrointestinal_hemorrhage | 1.60828088 |
| 47 | MP0008058_abnormal_DNA_repair | 1.60563784 |
| 48 | MP0000858_altered_metastatic_potential | 1.58934188 |
| 49 | MP0006082_CNS_inflammation | 1.58495455 |
| 50 | MP0003300_gastrointestinal_ulcer | 1.57602881 |
| 51 | MP0008007_abnormal_cellular_replicative | 1.51018577 |
| 52 | MP0001845_abnormal_inflammatory_respons | 1.49468198 |
| 53 | MP0002019_abnormal_tumor_incidence | 1.49392508 |
| 54 | MP0004947_skin_inflammation | 1.48665271 |
| 55 | MP0003303_peritoneal_inflammation | 1.43653398 |
| 56 | MP0010352_gastrointestinal_tract_polyps | 1.38630814 |
| 57 | MP0002933_joint_inflammation | 1.34171342 |
| 58 | MP0002132_abnormal_respiratory_system | 1.32047748 |
| 59 | MP0003191_abnormal_cellular_cholesterol | 1.28058322 |
| 60 | MP0005174_abnormal_tail_pigmentation | 1.22300255 |
| 61 | MP0004381_abnormal_hair_follicle | 1.21706998 |
| 62 | MP0003045_fibrosis | 1.16645562 |
| 63 | MP0003656_abnormal_erythrocyte_physiolo | 1.16581876 |
| 64 | MP0006054_spinal_hemorrhage | 1.12973800 |
| 65 | MP0002277_abnormal_respiratory_mucosa | 1.06743576 |
| 66 | MP0008469_abnormal_protein_level | 1.06676204 |
| 67 | MP0000350_abnormal_cell_proliferation | 0.97729027 |
| 68 | MP0003828_pulmonary_edema | 0.97723001 |
| 69 | MP0000313_abnormal_cell_death | 0.97142756 |
| 70 | MP0002998_abnormal_bone_remodeling | 0.95256678 |
| 71 | MP0003448_altered_tumor_morphology | 0.93545870 |
| 72 | MP0001533_abnormal_skeleton_physiology | 0.93224369 |
| 73 | MP0005451_abnormal_body_composition | 0.92621714 |
| 74 | MP0002095_abnormal_skin_pigmentation | 0.84743146 |
| 75 | MP0004883_abnormal_blood_vessel | 0.83596144 |
| 76 | MP0008260_abnormal_autophagy | 0.82239783 |
| 77 | MP0002009_preneoplasia | 0.81831037 |
| 78 | MP0009278_abnormal_bone_marrow | 0.80530899 |
| 79 | MP0004130_abnormal_muscle_cell | 0.79992569 |
| 80 | MP0010307_abnormal_tumor_latency | 0.78606399 |
| 81 | MP0001730_embryonic_growth_arrest | 0.78451626 |
| 82 | MP0003786_premature_aging | 0.77086130 |
| 83 | MP0009763_increased_sensitivity_to | 0.73849104 |
| 84 | MP0001851_eye_inflammation | 0.72566224 |
| 85 | MP0002138_abnormal_hepatobiliary_system | 0.70133257 |
| 86 | MP0000015_abnormal_ear_pigmentation | 0.69421049 |
| 87 | MP0005166_decreased_susceptibility_to | 0.67952491 |
| 88 | MP0005310_abnormal_salivary_gland | 0.67772489 |
| 89 | MP0000477_abnormal_intestine_morphology | 0.67373797 |
| 90 | MP0004510_myositis | 0.65552802 |
| 91 | MP0005023_abnormal_wound_healing | 0.64811563 |
| 92 | MP0005390_skeleton_phenotype | 0.63883766 |
| 93 | MP0008961_abnormal_basal_metabolism | 0.63584314 |
| 94 | MP0001663_abnormal_digestive_system | 0.63200033 |
| 95 | MP0003172_abnormal_lysosome_physiology | 0.63125313 |
| 96 | MP0002693_abnormal_pancreas_physiology | 0.62603928 |
| 97 | MP0000604_amyloidosis | 0.61613297 |
| 98 | MP0009765_abnormal_xenobiotic_induced | 0.60579812 |
| 99 | MP0008932_abnormal_embryonic_tissue | 0.58499098 |
| 100 | MP0008873_increased_physiological_sensi | 0.57836805 |
| 101 | MP0008877_abnormal_DNA_methylation | 0.57813748 |
| 102 | MP0002080_prenatal_lethality | 0.57475620 |
| 103 | MP0002163_abnormal_gland_morphology | 0.56925383 |
| 104 | MP0003186_abnormal_redox_activity | 0.56416507 |
| 105 | MP0000371_diluted_coat_color | 0.56176124 |
| 106 | MP0004147_increased_porphyrin_level | 0.56033812 |
| 107 | MP0003795_abnormal_bone_structure | 0.55417562 |
| 108 | MP0005076_abnormal_cell_differentiation | 0.54793380 |
| 109 | MP0003690_abnormal_glial_cell | 0.54533063 |
| 110 | MP0000249_abnormal_blood_vessel | 0.54329281 |
| 111 | MP0001919_abnormal_reproductive_system | 0.52585292 |
| 112 | MP0005164_abnormal_response_to | 0.52098023 |
| 113 | MP0000343_altered_response_to | 0.51185535 |
| 114 | MP0001348_abnormal_lacrimal_gland | 0.48101414 |
| 115 | MP0000609_abnormal_liver_physiology | 0.48012889 |
| 116 | MP0000358_abnormal_cell_content/ | 0.46642033 |
| 117 | MP0002086_abnormal_extraembryonic_tissu | 0.46563674 |
| 118 | MP0000598_abnormal_liver_morphology | 0.46333647 |
| 119 | MP0002970_abnormal_white_adipose | 0.45724550 |
| 120 | MP0009764_decreased_sensitivity_to | 0.45612913 |
| 121 | MP0002136_abnormal_kidney_physiology | 0.45473401 |
| 122 | MP0001986_abnormal_taste_sensitivity | 0.45158527 |
| 123 | MP0001501_abnormal_sleep_pattern | 0.44944351 |
| 124 | MP0001697_abnormal_embryo_size | 0.44220199 |
| 125 | MP0001765_abnormal_ion_homeostasis | 0.41784830 |
| 126 | MP0009840_abnormal_foam_cell | 0.39716684 |
| 127 | MP0005083_abnormal_biliary_tract | 0.39514850 |
| 128 | MP0008874_decreased_physiological_sensi | 0.36769669 |
| 129 | MP0003252_abnormal_bile_duct | 0.34796994 |
| 130 | MP0004185_abnormal_adipocyte_glucose | 0.34220507 |
| 131 | MP0008995_early_reproductive_senescence | 0.34054291 |
| 132 | MP0005381_digestive/alimentary_phenotyp | 0.34009955 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | T lymphocytopenia (HP:0005403) | 5.61933142 |
| 2 | Abnormality of T cell number (HP:0011839) | 5.35530308 |
| 3 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.92827848 |
| 4 | Chronic otitis media (HP:0000389) | 4.90697616 |
| 5 | Abnormality of T cells (HP:0002843) | 4.53336714 |
| 6 | IgM deficiency (HP:0002850) | 4.43911883 |
| 7 | Severe combined immunodeficiency (HP:0004430) | 4.38269732 |
| 8 | Gastrointestinal infarctions (HP:0005244) | 4.30308589 |
| 9 | Abnormal number of erythroid precursors (HP:0012131) | 4.29202057 |
| 10 | Recurrent viral infections (HP:0004429) | 4.23164556 |
| 11 | Combined immunodeficiency (HP:0005387) | 4.19590822 |
| 12 | Abnormality of cells of the erythroid lineage (HP:0012130) | 4.18450051 |
| 13 | Recurrent bronchitis (HP:0002837) | 4.16037419 |
| 14 | Panhypogammaglobulinemia (HP:0003139) | 4.14462576 |
| 15 | Orchitis (HP:0100796) | 4.07137558 |
| 16 | Recurrent fungal infections (HP:0002841) | 4.01503472 |
| 17 | Thrombocytosis (HP:0001894) | 3.89219004 |
| 18 | Abnormality of macrophages (HP:0004311) | 3.86132605 |
| 19 | Nasal polyposis (HP:0100582) | 3.73030653 |
| 20 | IgG deficiency (HP:0004315) | 3.67107256 |
| 21 | Abnormality of B cell number (HP:0010975) | 3.60817513 |
| 22 | B lymphocytopenia (HP:0010976) | 3.60817513 |
| 23 | Aplastic anemia (HP:0001915) | 3.48120102 |
| 24 | Myositis (HP:0100614) | 3.47743302 |
| 25 | Reticulocytopenia (HP:0001896) | 3.45482763 |
| 26 | Abnormality of T cell physiology (HP:0011840) | 3.44515584 |
| 27 | Hypoplasia of the thymus (HP:0000778) | 3.39000436 |
| 28 | Eosinophilia (HP:0001880) | 3.34670299 |
| 29 | Stomatitis (HP:0010280) | 3.34254139 |
| 30 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.30118218 |
| 31 | Recurrent cutaneous fungal infections (HP:0011370) | 3.30118218 |
| 32 | Abnormality of eosinophils (HP:0001879) | 3.29726153 |
| 33 | Eczematoid dermatitis (HP:0000976) | 3.25322312 |
| 34 | Granulocytopenia (HP:0001913) | 3.21673416 |
| 35 | Petechiae (HP:0000967) | 3.17560976 |
| 36 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.17371491 |
| 37 | Chest pain (HP:0100749) | 3.09615155 |
| 38 | Abnormality of the nasal mucosa (HP:0000433) | 3.07562356 |
| 39 | Recurrent abscess formation (HP:0002722) | 3.04876926 |
| 40 | Lymphoma (HP:0002665) | 3.04081359 |
| 41 | Meningitis (HP:0001287) | 2.99482979 |
| 42 | Thyroiditis (HP:0100646) | 2.99143966 |
| 43 | Lymphopenia (HP:0001888) | 2.98175685 |
| 44 | Leukocytosis (HP:0001974) | 2.96801941 |
| 45 | Keratoconjunctivitis sicca (HP:0001097) | 2.96370789 |
| 46 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.94469890 |
| 47 | Abnormality of the fingertips (HP:0001211) | 2.87400232 |
| 48 | Hypochromic anemia (HP:0001931) | 2.84555611 |
| 49 | Keratoconjunctivitis (HP:0001096) | 2.84033946 |
| 50 | Papilledema (HP:0001085) | 2.78985830 |
| 51 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.76835948 |
| 52 | Prolonged bleeding time (HP:0003010) | 2.75623873 |
| 53 | Gingivitis (HP:0000230) | 2.73425231 |
| 54 | Autoimmune hemolytic anemia (HP:0001890) | 2.71413416 |
| 55 | Pustule (HP:0200039) | 2.69952291 |
| 56 | Basal cell carcinoma (HP:0002671) | 2.67892044 |
| 57 | Hypochromic microcytic anemia (HP:0004840) | 2.66907977 |
| 58 | Abnormality of the prostate (HP:0008775) | 2.66603165 |
| 59 | Mediastinal lymphadenopathy (HP:0100721) | 2.64158692 |
| 60 | Pulmonary embolism (HP:0002204) | 2.58451631 |
| 61 | Chronic diarrhea (HP:0002028) | 2.56261686 |
| 62 | Chronic obstructive pulmonary disease (HP:0006510) | 2.55575323 |
| 63 | Obstructive lung disease (HP:0006536) | 2.55575323 |
| 64 | Colitis (HP:0002583) | 2.53761924 |
| 65 | Epistaxis (HP:0000421) | 2.52137619 |
| 66 | Stomach cancer (HP:0012126) | 2.44749313 |
| 67 | Pallor (HP:0000980) | 2.43771093 |
| 68 | Recurrent skin infections (HP:0001581) | 2.39813246 |
| 69 | Recurrent bacterial skin infections (HP:0005406) | 2.38888205 |
| 70 | Anorexia (HP:0002039) | 2.38516092 |
| 71 | Arterial thrombosis (HP:0004420) | 2.37573498 |
| 72 | Encephalitis (HP:0002383) | 2.37473543 |
| 73 | Autoimmune thrombocytopenia (HP:0001973) | 2.36343042 |
| 74 | Urticaria (HP:0001025) | 2.34406668 |
| 75 | Joint swelling (HP:0001386) | 2.32321386 |
| 76 | Acute hepatic failure (HP:0006554) | 2.30982391 |
| 77 | Bronchitis (HP:0012387) | 2.30846518 |
| 78 | Hemoptysis (HP:0002105) | 2.28790233 |
| 79 | Abnormal platelet volume (HP:0011876) | 2.26324697 |
| 80 | Microcytic anemia (HP:0001935) | 2.25837382 |
| 81 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.25243575 |
| 82 | Agammaglobulinemia (HP:0004432) | 2.24576134 |
| 83 | Reduced antithrombin III activity (HP:0001976) | 2.24574384 |
| 84 | Poikiloderma (HP:0001029) | 2.24409499 |
| 85 | Gangrene (HP:0100758) | 2.24035308 |
| 86 | Chronic sinusitis (HP:0011109) | 2.22590227 |
| 87 | Myelodysplasia (HP:0002863) | 2.21877965 |
| 88 | Gingival bleeding (HP:0000225) | 2.21517187 |
| 89 | Episodic fever (HP:0001954) | 2.21340922 |
| 90 | Pancytopenia (HP:0001876) | 2.21337016 |
| 91 | IgA deficiency (HP:0002720) | 2.21081429 |
| 92 | Hypergammaglobulinemia (HP:0010702) | 2.18863689 |
| 93 | Vasculitis (HP:0002633) | 2.18440462 |
| 94 | Macrocytic anemia (HP:0001972) | 2.17959123 |
| 95 | Spontaneous hematomas (HP:0007420) | 2.17901238 |
| 96 | Glomerulopathy (HP:0100820) | 2.17162895 |
| 97 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.15879439 |
| 98 | Aplasia/Hypoplasia of the thymus (HP:0010515) | 2.12849954 |
| 99 | 11 pairs of ribs (HP:0000878) | 2.10234093 |
| 100 | Birth length less than 3rd percentile (HP:0003561) | 2.09066020 |
| 101 | Recurrent sinusitis (HP:0011108) | 2.08614683 |
| 102 | Amaurosis fugax (HP:0100576) | 2.07910821 |
| 103 | Gastrointestinal inflammation (HP:0004386) | 2.07082311 |
| 104 | Chromsome breakage (HP:0040012) | 2.04978944 |
| 105 | Slow saccadic eye movements (HP:0000514) | 2.03366554 |
| 106 | Abnormality of DNA repair (HP:0003254) | 2.02270882 |
| 107 | Abnormality of chromosome stability (HP:0003220) | 2.01235328 |
| 108 | Inflammation of the large intestine (HP:0002037) | 2.00619245 |
| 109 | Abnormality of the pleura (HP:0002103) | 1.99928849 |
| 110 | Sepsis (HP:0100806) | 1.99659663 |
| 111 | Keratitis (HP:0000491) | 1.98724769 |
| 112 | Increased IgM level (HP:0003496) | 1.98437619 |
| 113 | Hematochezia (HP:0002573) | 1.97276857 |
| 114 | Pulmonary infiltrates (HP:0002113) | 1.97167996 |
| 115 | Abnormal platelet function (HP:0011869) | 1.96632453 |
| 116 | Impaired platelet aggregation (HP:0003540) | 1.96632453 |
| 117 | Pulmonary fibrosis (HP:0002206) | 1.96017740 |
| 118 | Oral leukoplakia (HP:0002745) | 1.95145674 |
| 119 | Type I transferrin isoform profile (HP:0003642) | 1.94834903 |
| 120 | Papilloma (HP:0012740) | 1.94196083 |
| 121 | Verrucae (HP:0200043) | 1.94196083 |
| 122 | Cellulitis (HP:0100658) | 1.93217040 |
| 123 | Neutropenia (HP:0001875) | 1.93077400 |
| 124 | Hypoproteinemia (HP:0003075) | 1.91428936 |
| 125 | Bone marrow hypocellularity (HP:0005528) | 1.90654680 |
| 126 | Increased IgE level (HP:0003212) | 1.89086611 |
| 127 | Optic neuritis (HP:0100653) | 1.88913630 |
| 128 | Retrobulbar optic neuritis (HP:0100654) | 1.88913630 |
| 129 | Cellular immunodeficiency (HP:0005374) | 1.87871568 |
| 130 | Skin ulcer (HP:0200042) | 1.85960459 |
| 131 | Osteomyelitis (HP:0002754) | 1.80225568 |
| 132 | Hemiplegia (HP:0002301) | 1.80133478 |
| 133 | Polyneuropathy (HP:0001271) | 1.79101532 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 5.04359449 |
| 2 | TXK | 4.57225853 |
| 3 | RIPK4 | 2.95825775 |
| 4 | ZAP70 | 2.64975024 |
| 5 | ITK | 2.60989136 |
| 6 | JAK3 | 2.56145875 |
| 7 | STK10 | 2.54045958 |
| 8 | EEF2K | 2.38728392 |
| 9 | CDC7 | 2.32629991 |
| 10 | TEC | 2.21458541 |
| 11 | PRPF4B | 2.18726248 |
| 12 | TYK2 | 2.18182827 |
| 13 | NME2 | 2.12779773 |
| 14 | GRK6 | 1.88934153 |
| 15 | IKBKE | 1.88364451 |
| 16 | BTK | 1.88218757 |
| 17 | STK16 | 1.84840004 |
| 18 | CLK1 | 1.73077852 |
| 19 | FGFR4 | 1.72797513 |
| 20 | KIT | 1.71539919 |
| 21 | CAMKK2 | 1.66676221 |
| 22 | WEE1 | 1.64228553 |
| 23 | SIK3 | 1.63976125 |
| 24 | EPHB1 | 1.59156173 |
| 25 | TESK2 | 1.57490211 |
| 26 | LCK | 1.56483608 |
| 27 | NLK | 1.54465229 |
| 28 | SYK | 1.53973505 |
| 29 | ACVR1B | 1.50600226 |
| 30 | FLT3 | 1.50271898 |
| 31 | MAP3K10 | 1.45452423 |
| 32 | KDR | 1.39047089 |
| 33 | LRRK2 | 1.33328807 |
| 34 | TBK1 | 1.32893106 |
| 35 | JAK1 | 1.32828564 |
| 36 | BLK | 1.31574220 |
| 37 | PIM2 | 1.31129622 |
| 38 | CAMKK1 | 1.30363764 |
| 39 | PKN2 | 1.29433925 |
| 40 | RPS6KA4 | 1.25046187 |
| 41 | PIM1 | 1.23272248 |
| 42 | IRAK4 | 1.20293368 |
| 43 | MAP3K14 | 1.17652062 |
| 44 | BUB1 | 1.12770444 |
| 45 | HCK | 1.11163052 |
| 46 | NEK2 | 1.10252379 |
| 47 | CSK | 1.09486782 |
| 48 | FGFR3 | 1.07754746 |
| 49 | MST4 | 1.06773672 |
| 50 | CDK4 | 1.05242687 |
| 51 | ERN1 | 1.04211666 |
| 52 | TSSK6 | 1.03874157 |
| 53 | EIF2AK1 | 1.02872605 |
| 54 | PASK | 1.02290869 |
| 55 | MAP2K2 | 0.99508986 |
| 56 | ATR | 0.99451022 |
| 57 | VRK1 | 0.98639176 |
| 58 | RPS6KB2 | 0.98508977 |
| 59 | MAP2K3 | 0.97539819 |
| 60 | CSF1R | 0.95321157 |
| 61 | SRPK1 | 0.93151410 |
| 62 | FES | 0.91734010 |
| 63 | STK4 | 0.89707756 |
| 64 | SCYL2 | 0.89507007 |
| 65 | TGFBR1 | 0.88802435 |
| 66 | EPHA3 | 0.87890142 |
| 67 | LYN | 0.85410262 |
| 68 | EIF2AK3 | 0.84652445 |
| 69 | MAP3K1 | 0.84300718 |
| 70 | MAP3K3 | 0.79938065 |
| 71 | IKBKB | 0.79858281 |
| 72 | TAOK3 | 0.79327728 |
| 73 | JAK2 | 0.74409295 |
| 74 | FGR | 0.73947893 |
| 75 | MAP3K8 | 0.72543347 |
| 76 | BRSK2 | 0.72381801 |
| 77 | MAPK7 | 0.72329293 |
| 78 | TNK2 | 0.70867971 |
| 79 | TLK1 | 0.68799017 |
| 80 | CDK7 | 0.66963928 |
| 81 | PRKCQ | 0.66225797 |
| 82 | PDK1 | 0.64566675 |
| 83 | MAPK12 | 0.64243900 |
| 84 | TYRO3 | 0.63280184 |
| 85 | MARK2 | 0.60865538 |
| 86 | AURKB | 0.60548609 |
| 87 | MAP3K12 | 0.60281118 |
| 88 | BMPR2 | 0.60270709 |
| 89 | FYN | 0.59188616 |
| 90 | MAPK4 | 0.55210413 |
| 91 | MARK3 | 0.53760505 |
| 92 | NEK6 | 0.50993532 |
| 93 | MAPK11 | 0.50753044 |
| 94 | MAP3K7 | 0.50118820 |
| 95 | PLK1 | 0.49665695 |
| 96 | DAPK1 | 0.47707142 |
| 97 | MAP3K11 | 0.47311855 |
| 98 | RPS6KA6 | 0.47046341 |
| 99 | TRIB3 | 0.46191673 |
| 100 | CCNB1 | 0.45123060 |
| 101 | SIK1 | 0.45101359 |
| 102 | RAF1 | 0.44592204 |
| 103 | CDK12 | 0.43697946 |
| 104 | PTK6 | 0.43452445 |
| 105 | PTK2B | 0.43401096 |
| 106 | CDC42BPA | 0.42834406 |
| 107 | CHEK1 | 0.42534246 |
| 108 | CDK6 | 0.42237942 |
| 109 | PRKCH | 0.41978282 |
| 110 | IRAK1 | 0.40905919 |
| 111 | TAOK1 | 0.40756401 |
| 112 | CDK19 | 0.40204056 |
| 113 | MAP3K13 | 0.39781948 |
| 114 | PIK3CG | 0.39641687 |
| 115 | DYRK3 | 0.39543081 |
| 116 | STK38 | 0.37217931 |
| 117 | GRK7 | 0.37132090 |
| 118 | HIPK2 | 0.35919371 |
| 119 | RPS6KL1 | 0.35330090 |
| 120 | RPS6KC1 | 0.35330090 |
| 121 | SMG1 | 0.35260439 |
| 122 | CHUK | 0.34928382 |
| 123 | PDGFRB | 0.34879420 |
| 124 | ATM | 0.33967705 |
| 125 | BRSK1 | 0.33939699 |
| 126 | RPS6KA5 | 0.33374192 |
| 127 | PRKD2 | 0.32614377 |
| 128 | TRPM7 | 0.31155742 |
| 129 | SIK2 | 0.31106869 |
| 130 | CSNK2A2 | 0.31047093 |
| 131 | MELK | 0.30919504 |
| 132 | MAPKAPK2 | 0.30884896 |
| 133 | YES1 | 0.30836305 |
| 134 | CAMK4 | 0.30711087 |
| 135 | MATK | 0.29508359 |
| 136 | MAP2K6 | 0.29118900 |
| 137 | RET | 0.29111807 |
| 138 | MAPK3 | 0.27960707 |
| 139 | TAOK2 | 0.27679511 |
| 140 | STK11 | 0.26508691 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 4.55765003 |
| 2 | DNA replication_Homo sapiens_hsa03030 | 4.25578308 |
| 3 | Ribosome_Homo sapiens_hsa03010 | 3.13742619 |
| 4 | Mismatch repair_Homo sapiens_hsa03430 | 3.03068776 |
| 5 | Base excision repair_Homo sapiens_hsa03410 | 2.45912830 |
| 6 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 2.43842787 |
| 7 | Homologous recombination_Homo sapiens_hsa03440 | 2.25523020 |
| 8 | Measles_Homo sapiens_hsa05162 | 2.23547625 |
| 9 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.21460464 |
| 10 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.16409673 |
| 11 | Non-homologous end-joining_Homo sapiens_hsa03450 | 2.14730948 |
| 12 | Spliceosome_Homo sapiens_hsa03040 | 2.13775223 |
| 13 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.10931882 |
| 14 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.89120520 |
| 15 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.88191146 |
| 16 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.88021305 |
| 17 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.85683854 |
| 18 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.85583869 |
| 19 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.84191257 |
| 20 | Allograft rejection_Homo sapiens_hsa05330 | 1.74596732 |
| 21 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.66863624 |
| 22 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.63206436 |
| 23 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.60280313 |
| 24 | Proteasome_Homo sapiens_hsa03050 | 1.59372099 |
| 25 | Leishmaniasis_Homo sapiens_hsa05140 | 1.56601405 |
| 26 | Cell cycle_Homo sapiens_hsa04110 | 1.56182122 |
| 27 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.51897194 |
| 28 | RNA transport_Homo sapiens_hsa03013 | 1.45920887 |
| 29 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.43081371 |
| 30 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.42006880 |
| 31 | RNA polymerase_Homo sapiens_hsa03020 | 1.40004193 |
| 32 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.33039728 |
| 33 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.28010394 |
| 34 | RNA degradation_Homo sapiens_hsa03018 | 1.23787051 |
| 35 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.19736547 |
| 36 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.19218300 |
| 37 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.14750750 |
| 38 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.10244718 |
| 39 | Hepatitis B_Homo sapiens_hsa05161 | 1.09832686 |
| 40 | Viral myocarditis_Homo sapiens_hsa05416 | 1.09646033 |
| 41 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.06741645 |
| 42 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.04237740 |
| 43 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.00673754 |
| 44 | HTLV-I infection_Homo sapiens_hsa05166 | 0.99784394 |
| 45 | Asthma_Homo sapiens_hsa05310 | 0.96057409 |
| 46 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.92730588 |
| 47 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.92547234 |
| 48 | Legionellosis_Homo sapiens_hsa05134 | 0.90415666 |
| 49 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.89006921 |
| 50 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.88870960 |
| 51 | Apoptosis_Homo sapiens_hsa04210 | 0.87878817 |
| 52 | Influenza A_Homo sapiens_hsa05164 | 0.87245280 |
| 53 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.87032034 |
| 54 | Shigellosis_Homo sapiens_hsa05131 | 0.86663641 |
| 55 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.85993156 |
| 56 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.85694551 |
| 57 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.84955384 |
| 58 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.80131026 |
| 59 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.79325448 |
| 60 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.77332668 |
| 61 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.77147318 |
| 62 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.75972307 |
| 63 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.74375761 |
| 64 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.74180355 |
| 65 | Basal transcription factors_Homo sapiens_hsa03022 | 0.70977863 |
| 66 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.70444165 |
| 67 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.70359236 |
| 68 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.70064377 |
| 69 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.68136564 |
| 70 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.68045649 |
| 71 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.67256769 |
| 72 | Colorectal cancer_Homo sapiens_hsa05210 | 0.67141432 |
| 73 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.66881057 |
| 74 | Purine metabolism_Homo sapiens_hsa00230 | 0.66357606 |
| 75 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.64532722 |
| 76 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.64515042 |
| 77 | Endocytosis_Homo sapiens_hsa04144 | 0.63849468 |
| 78 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.63642229 |
| 79 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.63523896 |
| 80 | Thyroid cancer_Homo sapiens_hsa05216 | 0.63391018 |
| 81 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.61666823 |
| 82 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.61422172 |
| 83 | Platelet activation_Homo sapiens_hsa04611 | 0.60985536 |
| 84 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.60237050 |
| 85 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.60161352 |
| 86 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.57619896 |
| 87 | Sulfur relay system_Homo sapiens_hsa04122 | 0.57549543 |
| 88 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.53309362 |
| 89 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.52789781 |
| 90 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.50753246 |
| 91 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.49377818 |
| 92 | Tuberculosis_Homo sapiens_hsa05152 | 0.49038694 |
| 93 | Endometrial cancer_Homo sapiens_hsa05213 | 0.46378395 |
| 94 | Protein export_Homo sapiens_hsa03060 | 0.45404879 |
| 95 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.44884334 |
| 96 | Insulin resistance_Homo sapiens_hsa04931 | 0.44667639 |
| 97 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.44612914 |
| 98 | Other glycan degradation_Homo sapiens_hsa00511 | 0.44582386 |
| 99 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.44076577 |
| 100 | Pertussis_Homo sapiens_hsa05133 | 0.43691580 |
| 101 | Hepatitis C_Homo sapiens_hsa05160 | 0.42800935 |
| 102 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.42477178 |
| 103 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.42399305 |
| 104 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.41185100 |
| 105 | Malaria_Homo sapiens_hsa05144 | 0.40110676 |
| 106 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.39984601 |
| 107 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.39274648 |
| 108 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.38551496 |
| 109 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.37419868 |
| 110 | Long-term potentiation_Homo sapiens_hsa04720 | 0.36108187 |
| 111 | Phagosome_Homo sapiens_hsa04145 | 0.34870631 |
| 112 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.34077782 |
| 113 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.32613985 |
| 114 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.32255719 |
| 115 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.30830279 |
| 116 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.30426378 |
| 117 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.29160759 |
| 118 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.28708713 |
| 119 | Prostate cancer_Homo sapiens_hsa05215 | 0.27982410 |
| 120 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.27564785 |
| 121 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.27226082 |
| 122 | Salmonella infection_Homo sapiens_hsa05132 | 0.26860369 |
| 123 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.26486776 |
| 124 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.26010675 |
| 125 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.25646511 |
| 126 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.24469378 |
| 127 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.23648578 |
| 128 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.23539106 |
| 129 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.23288469 |
| 130 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.22121988 |
| 131 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.21745214 |
| 132 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.21717576 |
| 133 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.21307023 |
| 134 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.19933643 |
| 135 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.19550998 |

